News tagged with anticoagulation therapy
Operating without interrupting warfarin reduces risk of bleeding after cardiac device surgery
A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current ...
Cardiology
May 09, 2013 |
not rated yet |
0
Low-dose anticoagulation therapy used with new design mechanical heart valve lowers bleeding risk
For more than 40 years, patients under 65 years of age requiring heart valve replacement have had to choose between a mechanical valve that offers life-long durability but requires aggressive warfarin anticoagulation or a ...
Cardiology
May 06, 2013 |
not rated yet |
0
Kcentra approved to stop severe bleeding in heart patients
(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...
Medications
Apr 30, 2013 |
not rated yet |
0
ASCO: anticoagulant use predicts metastatic prostate CA survival
(HealthDay)—Anticoagulant use is associated with improved overall survival in men receiving docetaxel chemotherapy for treatment of metastatic castration-resistant prostate cancer (mCRPC), according to ...
Cancer
Feb 19, 2013 |
not rated yet |
0
Ultrasonic testing with Doppler imaging can rule out blood clots in pregnant women
The use of serial compression ultrasonographic testing together with Doppler imaging appears to be a reliable method of ruling out blood clots in the legs of pregnant women, according to a study published in CMAJ (Canadian Medical A ...
Diseases, Conditions, Syndromes
Jan 14, 2013 |
not rated yet |
0
Study examines anticoagulation treatment following aortic valve replacement
Although current guidelines recommend 3 months of anticoagulation treatment after bioprosthetic aortic valve replacement surgery, a study that included more than 4,000 patients found that patients who had warfarin therapy ...
Cardiology
Nov 27, 2012 |
not rated yet |
0
|
Resuming warfarin after gastrointestinal tract bleeding linked with lower risk for thrombosis, death
A study of patients treated with the anticoagulant medication warfarin suggests that resuming warfarin therapy after an episode of gastrointestinal tract bleeding was associated with lower risk for thrombosis (blood clot) ...
Diseases, Conditions, Syndromes
Sep 17, 2012 |
not rated yet |
0
Omission of aspirin from antiplatelet regimen: The WOEST study
Lifelong anticoagulation is necessary for the prevention of stroke in patients with rhythm disturbances and with mechanical valves. Patients who have a coronary stent implanted also need the antiplatelet drugs aspirin and ...
Cardiology
Aug 28, 2012 |
not rated yet |
0
Safety indicators confirmed for common treatment of heart defect
A new study by medical scientists coordinated from the University of Manchester has for the first time used patients' results to establish that "safety indicators" for people taking anticoagulant drugs to regulate a common ...
Cardiology
Jul 03, 2012 |
not rated yet |
0
Innovations in anticoagulation for stroke prevention
New scientific findings in anticoagulation for stroke prevention are paving the way for updates to the European Society of Cardiology (ESC) Guidelines for the management of atrial fibrillation.
Cardiology
Jun 13, 2012 |
not rated yet |
0
Risk of stroke greater for women than men among older patients diagnosed with atrial fibrillation
In a study that examined use of the anticoagulant medication warfarin and risk of stroke following a diagnosis of atrial fibrillation in older patients, women, especially those 75 years or older, had a higher risk of stroke ...
Cardiology
May 08, 2012 |
not rated yet |
0
|
Final 3 year results from the landmark HORIZONS-AMI trial published in the Lancet
Data from the landmark HORIZONS-AMI clinical trial demonstrated that the administration of the anticoagulant medication bivalirudin enhanced survival compared to the use of heparin plus a glycoprotein (GP) IIb/IIIa inhibitor ...
Cardiology
Jun 13, 2011 |
not rated yet |
0